Systemic and ocular outcomes in TB-immunoreactive patients receiving immunomodulatory therapy for non-infectious uveitis: a case-control study.

Shravya Choudhary BallaMohammed Hasnat AliMudit TyagiSoumyava Basu

Published in: The British journal of ophthalmology (2024)

Conventional IMT has a very low risk of systemic TB reactivation, and no additional detrimental effect on ocular outcomes, in TB-immunoreactive patients with non-infectious uveitis.

Keyphrases

mycobacterium tuberculosis
juvenile idiopathic arthritis
ankylosing spondylitis
type diabetes
optic nerve
metabolic syndrome
adipose tissue
systemic lupus erythematosus
drug induced
optical coherence tomography